Works matching AU Reiser, M.


Results: 484
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    MRT der Prostata.

    Published in:
    2017
    By:
    • Nörenberg, D.;
    • Solyanik, O.;
    • Schlenker, B.;
    • Magistro, G.;
    • Ertl-Wagner, B.;
    • Clevert, D.;
    • Stief, C.;
    • Reiser, M.;
    • D'Anastasi, M.;
    • Nörenberg, D;
    • Clevert, D A;
    • Reiser, M F
    Publication type:
    journal article
    14
    15
    16

    Der petromastoidale Kanal.

    Published in:
    HNO (0017-6192), 2009, v. 57, n. 2, p. 142, doi. 10.1007/s00106-008-1785-z
    By:
    • Steinbach, S.;
    • Fitzthum, A.;
    • Reiser, M.;
    • Hundt, W.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAïVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE CLL12 TRIAL.

    Published in:
    Hematological Oncology, 2023, v. 41, p. 56, doi. 10.1002/hon.3163_24
    By:
    • Langerbeins, P.;
    • Robrecht, S.;
    • Nieper, P.;
    • Cramer, P.;
    • Fürstenau, M.;
    • Al‐Sawaf, O.;
    • Fink, A.;
    • Kreuzer, K.;
    • Vehling‐Kaiser, U.;
    • Tausch, E.;
    • Schneider, C.;
    • Müller, L.;
    • Schlag, R.;
    • Freier, W.;
    • Gaska, T.;
    • Balser, C.;
    • Reiser, M.;
    • Stauch, M.;
    • Zahn, M.;
    • Dörfel, S.
    Publication type:
    Article
    39

    IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAÏVE EARLY STAGE CLL: PRIMARY ENDPOINT RESULTS OF THE PHASE 3 DOUBLE‐BLIND RANDOMIZED CLL12 TRIAL.

    Published in:
    Hematological Oncology, 2019, v. 37, p. 38, doi. 10.1002/hon.7_2629
    By:
    • Langerbeins, P.;
    • Bahlo, J.;
    • Rhein, C.;
    • Gerwin, H.;
    • Cramer, P.;
    • Fürstenau, M.;
    • Al‐Sawaf, O.;
    • Tresckow, J.;
    • Fink, A.M.;
    • Kreuzer, K.;
    • Vehling‐Kaiser, U.;
    • Tausch, E.;
    • Müller, L.;
    • Eckart, M.;
    • Schlag, R.;
    • Freier, W.;
    • Gaska, T.;
    • Balser, C.;
    • Reiser, M.;
    • Stauch, M.
    Publication type:
    Article
    40

    IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAÏVE EARLY STAGE CLL: PRIMARY ENDPOINT RESULTS OF THE PHASE 3 DOUBLE‐BLIND RANDOMIZED CLL12 TRIAL.

    Published in:
    Hematological Oncology, 2019, v. 37, p. 38, doi. 10.1002/hon.7_2629
    By:
    • Langerbeins, P.;
    • Bahlo, J.;
    • Rhein, C.;
    • Gerwin, H.;
    • Cramer, P.;
    • Fürstenau, M.;
    • Al‐Sawaf, O.;
    • Tresckow, J.;
    • Fink, A.M.;
    • Kreuzer, K.;
    • Vehling‐Kaiser, U.;
    • Tausch, E.;
    • Müller, L.;
    • Eckart, M.;
    • Schlag, R.;
    • Freier, W.;
    • Gaska, T.;
    • Balser, C.;
    • Reiser, M.;
    • Stauch, M.
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50